Association of capsular polysaccharide locus 2 with prognosis of Acinetobacter baumannii bacteraemia

References

• Wong D, Nielsen TB, Bonomo RA, et al. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017 Jan;30(1):409–447.
   PubMed Web of Science ®Google Scholar
• Manikal VM, Landman D, Saurina G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis. 2000 Jul;31(1):101–106.
   PubMed Web of Science ®Google Scholar
• Garcia-Garmendia J-L, Ortiz-Leyba C, Garnacho-Montero J, et al. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med. 1999 Sep;27(9):1794–1799.
   PubMed Web of Science ®Google Scholar
• Chuang Y-C, Sheng W-H, Li S-Y, et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin Infect Dis. 2011 Feb 1;52(3):352–360.
   PubMed Web of Science ®Google Scholar
• Lee Y-T, Kuo S-C, Yang S-P, et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis. 2012 Jul;55(2):209–215.
   PubMed Web of Science ®Google Scholar
• Jones CL, Clancy M, Honnold C, et al. Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence. Clin Infect Dis. 2015 Jul 15;61(2):145–154.
   PubMed Web of Science ®Google Scholar
• Giannouli M, Antunes LCS, Marchetti V, et al. Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis. 2013 Jun 20;13:282.
   PubMed Web of Science ®Google Scholar
• Chuang Y-C, Cheng A, Sun H-Y, et al. Microbiological and clinical characteristics of Acinetobacter baumannii bacteremia: implications of sequence type for prognosis. J Infect. 2019 Feb;78(2):106–112.
   PubMed Web of Science ®Google Scholar
• Russo TA, Luke NR, Beanan JM, et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun. 2010 Sep;78(9):3993–4000.
   PubMed Web of Science ®Google Scholar
• Oliveira H, Mendes A, Fraga AG, et al. K2 capsule depolymerase is highly stable, is refractory to resistance, and protects larvae and mice from Acinetobacter baumannii sepsis. Appl Environ Microbiol. 2019 Sep 1;85(17):e00934–19.
   PubMed Web of Science ®Google Scholar
• Kenyon JJ, Marzaioli AM, Hall RM, et al. Structure of the K2 capsule associated with the KL2 gene cluster of Acinetobacter baumannii. Glycobiology. 2014 Jun;24(6):554–563.
   PubMed Web of Science ®Google Scholar
• Wyres KL, Cahill SM, Holt KE, et al. Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive. Microb Genom. 2020 Mar;6(3):e000339.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 29th informational supplement, M100S. Wayne (PA): CLSI; 2019.
   Google Scholar
• Fernandez-Mazarrasa C, Mazarrasa O, Calvo J, et al. High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest. J Clin Microbiol. 2009 Mar;47(3):827–829.
   PubMed Web of Science ®Google Scholar
• Diancourt L, Passet V, Nemec A, et al. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One. 2010;5(4):e10034.
   PubMed Web of Science ®Google Scholar
• Adams MD, Goglin K, Molyneaux N, et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol. 2008 Dec;190(24):8053–8064.
   PubMed Web of Science ®Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309–332.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents. 1999 Jan;11(1):7–12.
   PubMed Web of Science ®Google Scholar
• Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis. 2010 Jul 1;51(1):79–84.
   PubMed Web of Science ®Google Scholar
• Trevor CME. Healthcare-associated bloodstream infections. In: Mayhall CG, editor. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 258.
   Google Scholar
• Bozdogan H. Model selection and Akaike's information criterion (AIC): the general theory and its analytical extensions. Psychometrika. 1987 Sep;52(3):345–370.
   Web of Science ®Google Scholar
• Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol. 1982;13:290–312.
   Google Scholar
• Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986 Dec;51(6):1173–1182.
   PubMed Web of Science ®Google Scholar
• Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009 Jul;20(4):488–495.
   PubMed Web of Science ®Google Scholar
• Senchenkova SN, Shashkov AS, Shneider MM, et al. Structure of the capsular polysaccharide of Acinetobacter baumannii ACICU containing di-N-acetylpseudaminic acid. Carbohydr Res. 2014 Jun 4;391:89–92.
   PubMed Web of Science ®Google Scholar
• Knirel YA, Vinogradov EV, L'Vov VL, et al. Sialic acids of a new type from the lipopolysaccharides of Pseudomonas aeruginosa and Shigella boydii. Carbohydr Res. 1984 Oct 15;133(2):C5–C8.
   PubMed Web of Science ®Google Scholar
• Salah Ud-Din AIM, Roujeinikova A. Flagellin glycosylation with pseudaminic acid in Campylobacter and helicobacter: prospects for development of novel therapeutics. Cell Mol Life Sci. 2018 Apr;75(7):1163–1178.
   PubMed Web of Science ®Google Scholar
• Carlin AF, Uchiyama S, Chang Y-C, et al. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood. 2009 Apr 2;113(14):3333–3336.
   PubMed Web of Science ®Google Scholar
• Stephenson HN, Mills DC, Jones H, et al. Pseudaminic acid on Campylobacter jejuni flagella modulates dendritic cell IL-10 expression via Siglec-10 receptor: a novel flagellin-host interaction. J Infect Dis. 2014 Nov 1;210(9):1487–1498.
   PubMed Web of Science ®Google Scholar
• Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007 Apr;13(4):463–469.
   PubMed Web of Science ®Google Scholar
• Xiang B, Zhang G, Guo L, et al. Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat Commun. 2013;4:2657.
   PubMed Web of Science ®Google Scholar
• Zhang G, Han J, Welch EJ, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol. 2009 Jun 15;182(12):7997–8004.
   PubMed Web of Science ®Google Scholar
• Lin L, Tan B, Pantapalangkoor P, et al. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. mBio. 2012;3(5):e00312–12.
   PubMed Web of Science ®Google Scholar
• Bruhn KW, Pantapalangkoor P, Nielsen T, et al. Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia. J Infect Dis. 2015 Apr 15;211(8):1296–1305.
   PubMed Web of Science ®Google Scholar
• Hsieh Y-C, Wang S-H, Chen Y-Y, et al. Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii. Emerg Microbes Infect. 2020 Dec;9(1):2094–2104.
   PubMed Web of Science ®Google Scholar
• Silva L, Grosso F, Rodrigues C, et al. The success of particular Acinetobacter baumannii clones: accumulating resistance and virulence inside a sugary shield. J Antimicrob Chemother. 2021 Jan 19;76(2):305–311.
   PubMed Web of Science ®Google Scholar
• Russo TA, Beanan JM, Olson R, et al. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun. 2013 Mar;81(3):915–922.
   PubMed Web of Science ®Google Scholar
• Wei R, Yang X, Liu H, et al. Synthetic pseudaminic-acid-based antibacterial vaccine confers effective protection against Acinetobacter baumannii infection. ACS Cent Sci. 2021 Sep 22;7(9):1535–1542.
   PubMed Web of Science ®Google Scholar
• Menard R, Schoenhofen IC, Tao L, et al. Small-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factor. Antimicrob Agents Chemother. 2014 Dec;58(12):7430–7440.
   PubMed Web of Science ®Google Scholar